Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
MAP20250004689US healthcare : navigating through the headwinds. — New York : McKinsey & Company, 20259 p.Sumario: In 2024, US healthcare deal activity continued to slow after its peak in 2021, with total deals declining roughly 30 percent year over year. Headwinds included high multiple expectations, given prior valuations in key sectors (for example, healthcare services and technology); continued margin pressure for payers and providers, which limited the funds available for acquisitions; and regulatory uncertainty. In this article, we assess US deal activity in 2024, identify important developments since 2023, and highlight key insights across leading sectors1. Sanidad. 2. Fusiones y adquisiciones. 3. Asistencia sanitaria. 4. Análisis transaccional. 5. Operaciones financieras. 6. Sectores económicos. 7. Estados Unidos. I. McKinsey & Company.